Congenital heart disease interventions
Highlighted products for this procedure
Azurion 7 image-guided therapy system
When treating congenital heart disease, workflow standardization and streamlining help boost efficiency, save time, and enhance teamwork. The Azurion CHD suite was designed to integrate information from multiple sources and save procedure time through flexible and user-centric display and control options. By adapting to your workflow needs, the system works seamlessly around you so that you may focus on your patient. The Azurion platform also benefits from drastic radiation reduction specifically tuned for pediatric patients1, 2, 3.
Customer experiences with Philips CHD solutions
The ability to treat one more patient per day, or in the future
This is just one of the many improvements in lab performance achieved by the Interventional Vascular Department at St. Antonius Hospital after installing the Azurion system. The first Azurion lab performance study achieved impressive results which have been verified by an independent third party.
12%
25%
100%
17%
quality care4
44%
94%
12%
25%
100%
17%
quality care4
44%
94%
More Philips solutions for treating congenital heart disease
Interventional Ultrasound
Philips Ultrasound provides a wide range of transducers, from fetal to adult congenital, with dedicated imaging capabilities, workflow quantification, and powered by Anatomical Intelligence for routine quantification.
Ambient Experience
CHD patients and their parents often experience anxiety leading to a procedure, peaking when entering the unfamiliar cath lab environment. Ambient Experience creates an engaging, multi-sensorial environment that helps distract and relax patients. They can influence their own experience by selecting themes in dynamic lighting, music, and video. Ambient Experience also improves staff satisfaction, as well as the reputation and perception of hospitals through the testimonials of satisfied patients
IntelliSpace Portal
IntelliSpace CardioVascular applications provide powerful solutions for congenital care, including:
References 1 N.A. Haas, et al., Int J Cardiol Heart Vasc. 2015 Jan 20;6:101-109: Substantial radiation reduction in pediatric and adult congenital heart disease interventions with a novel X-ray imaging technology 2 P.M. Sullivan, et al. Pediatr Cardiol. 2017 Dec;38(8):1583-1591: Reduction in Radiation Dose in a Pediatric Cardiac Catheterization Lab Using the Philips AlluraClarity X-ray System 3 Results are specific to the institution where they were obtained and may not reflect the results achievable at other institutions. 4 Evaluated with clinical users in a simulated lab environment with a total of 17 teams consisting of a physician and a radiotech, and 1 physician without a radio-tech, with different levels of experience. 5 Results obtained during user demonstrations performed in December 2017 with the EPIQ CVx and the iE33 systems. The research was designed and supervised by Use- Lab GmbH, an independent and objective engineering consultancy and user interface design company. The tests involved 42 clinicians from 17 countries. 6 These functionalities may not be available in all territories. Please contact your Philips representative for more details. 7 Caas is a trademark of Pie Medical Inc. 8 Not intented for diagnostic use. 9 3D models are not intended for diagnostic use.
